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In 1912, Wilson first described a familial disorder as-
sociated with neurological symptoms and cirrhosis1. 
Wilson’s disease (WD) is an autosomal recessive inherit-
ed disorder of the copper metabolism. The ability to ex-
port copper from the liver into the bile and to incorpo-
rate copper into the hepatic caeruloplasmin is impaired. 
As a consequence, this element accumulates in the liver, 
brain and corneas, resulting in highly variable clinical fea-
tures, including chronic liver disease and/or neurological 
impairment2-4.
The gene defective in WD, ATP7B, that codes for a cop-
per-transporting CPx-type ATPase3. ATP7B (locus 13q14.3) 
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ABSTRACT
Objective: Wilson´s disease (WD) is an inborn error of metabolism caused by abnormalities of the copper-transporting protein encoding gene 
ATP7B. In this study, we examined ATP7B for mutations in a group of patients living in southern Brazil. Methods: 36 WD subjects were studied 
and classified according to their clinical and epidemiological data. In 23 subjects the ATP7B gene was analyzed. Results: Fourteen distinct 
mutations were detected in at least one of the alleles. The c.3207C>A substitution at exon 14 was the most common mutation (allelic fre-
quency=37.1%) followed by the c.3402delC at exon 15 (allelic frequency=11.4%). The mutations c.2018-2030del13 at exon 7 and c.4093InsT 
at exon 20 are being reported for the first time. Conclusion: The c.3207C>A substitution at exon 14, was the most common mutation, with an 
allelic frequency of 37.1%. This mutation is the most common mutation described in Europe.
Key words: hepatolenticular degeneration, signs and symptoms, genetics.
RESUMO
Objetivo: A doença de Wilson (DW) é um erro inato do metabolismo causado por abnormalidades no gene ATP7B, que codifica uma proteína 
transportadora de cobre. Neste estudo, avaliamos as mutações do gene ATP7B em um grupo de pacientes do sul do Brasil. Métodos: Foram 
estudados 36 pacientes com DW e classificados do ponto de vista clínico e epidemiológico. Em 23 pacientes, o gene ATP7B foi analisado. 
Resultados: A substituição c.3207C>A no éxon 14 foi a mutação mais comum seguida pela mutação c.3402delC no éxon 15 . A mutação 
c.2018-2030del13 no éxon 7 e a c.4093InsT no éxon 20 são relatadas pela primeira vez na literatura. Conclusão: A mutação do gene ATP7B, 
com a substituição c.3207C>A no éxon 14 foi a mais frequente. Esta mutação é a mais comumente encontrada em pacientes europeus.
Palavras-Chave: degeneração hepatolenticular, sinais e sintomas, genética.
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is a large gene, with 21 exons, spanning over a DNA region 
of approximately 100 kb, and encoding a protein of 1,465 
amino acids5. The ATP7B protein is expressed most abun-
dantly in the liver, however, it has also been demonstrated 
in the kidney, brain, lung, heart, mammary gland, and pla-
centa6. In the hepatocytes, this protein delivers copper to 
apocaeruloplasmin and mediates the excretion of the coo-
per excess into bile2-4. 
The worldwide prevalence of WD is estimated to range 
between 1 in 30,000 and 1 in 100,000, with a gene frequency of 
0.56% and a carrier frequency of approximately 1 in 907. 
Currently, there are records of at least 400 distinct dis-
ease-causing mutations in the ATP7B gene that can be as-
sociated with WD8, including missense, nonsense, deletions, 
insertions, splice site and point mutations. While most of 
these mutations are rare and only reported in single fami-
lies, some are clearly more common, accounting for a larger 
number of WD cases6. 
In most ethnic groups, either one or a small number of 
ATP7B mutations are prevalent, followed by many other rare 
mutations. Knowledge of the regional distribution of WD 
gene mutations is important when designing the appropri-
ate screening strategies9. 
The study of the frequency of mutations is difficult in 
countries with a highly mixed population like the United 
States, the United Kingdom3, and Brazil. Deguti et al.10 eval-
uated the ATP7B genotype of 60 WD patients from differ-
ent Brazilian regions, showing that the c.3402delC and the 
c.2123T>C were the most common, representing nearly 50% 
of all the mutations in the country.
 Therefore, to further understand the regional distribu-
tion of ATP7B mutations in Brazil, we focused our study to 
genetically analyze a WD population of southern Brazil char-
acterized by a predominantly European ancestry.
METHODS
Subjects
A total of 36 subjects, including 20 females (56.6%), 
with 34 white individuals (94,5%), were diagnosed with WD 
in this sample. All patients were followed at the Units of 
Neurology and/or Gastroenterology at the Clinical Hospital 
of the Universidade Federal do Paraná, a reference center in 
Curitiba, Brazil.
The diagnosis of WD was based on a combination of 
typical neurological symptoms, liver disturbances, Kayser-
Fleischer rings, biochemical, histological and imaging tests. 
One asymptomatic subject was diagnosed through familial 
genetic screening. 
The research was approved by the local Ethics Committee 
and informed consent was obtained from all subjects or from 
their parents before inclusion in the study. 
Clinical evaluation
Patients were classified according to their age, gender, 
family history and the presence of consanguinity. Whenever 
available, data of patients’ origin was obtained according to 
their knowledge of their furthest ancestral countries of ori-
gin. This information was later on classified as being purely 
European or a mixed European and undetermined Brazilian. 
Patients with the mixed ancestry were investigated to deter-
mine the possible presence of a native indigenous ancestor.
The age of the initial symptoms presentation was deter-
mined, and the time since the initial symptoms until the de-
finitive diagnosis was calculated in months. Patient’s clinical 
presentations were classified as predominantly hepatic, pre-
dominantly neuropsychiatric, mixed presentation (hepatic 
and neuropsychiatric) and asymptomatic.
Mutation analysis
In 23 of the 36 WD subjects the ATP7B gene was studied. 
Genomic DNA was successfully extracted from whole 
blood samples collected in EDTA tubes at room tempera-
ture (22ºC) by a DNA extractor kit (QIA amp® DNA mini kit, 
Qiagen, Hilden, Germany). 
The gene was amplified by PCR and the products of the 
reaction were subsequently purified using ExoSAP-IT (USB 
Corporation, Cleveland, USA) and direct sequencing was 
performed using a BigDye Terminator® in an automatic se-
quencer (Applied Biosystem, Darmstadt, Germany). 
RESULTS
Clinical evaluation
The mean age was of 34.6±10.8 (12–63) years. Mean age at 
the initial symptom presentation was 23.2± 9.3 (10–41) years. 
The mean time since the first clinical symptom and the de-
finitive diagnosis was 27.5±41.9 (1–194) months.
Family history was obtained in 16 (44.4%) patients and 
only 2 individuals (5.5%) described a history of parental 
consanguinity.
Data of patients’ origin was available from 31 patients 
(86.2%). All the original countries from their oldest known an-
cestors were accessed, being 16 (44.4%) from Italy, 8 (22.2%) 
from Poland, 8 (22.2%) from Brazil, 7 (19.4%) from Portugal, 
5 (13.8%) from Germany, 3 (8.3%) from Spain, 3 (8.3%) from 
Switzerland, 2 (5.6%) from Ukraine, 1 (2.7%) from Russia and 
1 (2.7%) from Ireland. This cohort of patients presented a 
high predominance of an exclusively European continental 
origin (n=23, 74.2%). Eight (25.8%) subjects reported mixed 
ancestry. Among them, 3 (37.5%) identified the presence of a 
native indigenous ancestor.
Among the 36 WD patients, 9 (25%) showed predomi-
nantly neuropsychiatric symptoms, 14 (38.9%) predominant-
ly hepatic symptoms, 11 (30.6%) demonstrated both hepatic 
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and neuropsychiatric features (mixed presentation) and 2 
(5.5%) were asymptomatic. The diagnosis among asymptom-
atic subjects was achieved through genetic family screening. 
Mutation Analysis
Fourteen distinct mutations were detected in at least 
one of the alleles among 23 of the 36 WD patients (Table 1). 
The c.3207C>A substitution at exon 14 was the most com-
mon mutation, with an allelic frequency of 37.1%, followed 
by the c.3402delC at exon 15, with an allelic frequency of 
11.4%. These two different mutations account for about 
48.5% of the alleles studied, thereby indicating that these 
exons are important regions for detecting mutations in 
southern Brazilian patients. 
The c.3207C>A is the most common mutation described 
in Europe. Its frequency is higher in Poland and eastern 
Germany and decreases to the west and to the south, with 
an allelic frequency ranging between 30 and 70% (9). The 
c.3402delC is the most common mutation described for 
the Brazilian population, with an allelic frequency of 30.8%10. 
Data of WD patients’ continental origin and their ATP7B 
identified mutations are described in table 2.
According to the literature, the mutations c.2018-
2030del13 at exon 7 and c.4093InsT at exon 20 are being 
Table 1. Characteristics of ATP7B mutations. 
Nucleotide change Amino acid Variant type Exon Allele frequency (n=35)
c.51+4 A -->T Insertion Intron 1 1/2.85%
c.1934T>G Met645Arg Substitution 6 1/2.85%
c.2018-2030 Deletion 7 1/2.85% (new)
c.2123T>C Leu708Pro Substitution 8 1/2.85%
c.2304delC Met769CysfsX38 Deletion 8 1/2.85%
c.2304dupC Met769HisfsX26 Duplication 8 3/8.57%
c.2305A>G Met769Val Substitution 8 1/2.85%
c.2336G>A Trp779Stop Substitution 8 3/8.57%
c.2672G>T Gly891Val Substitution 11 1/2.85%
c.2762G>A Ser921Asn Substitution 12 1/2.85%
c.3207C>A His1069Gln Substitution 14 13/37.1%
c.3402del C Ala1135Glnfs Deletion 15 4/11.4%
c.3818C>T Pro1273Leu Substitution 18 2/5.71%
c.4093InsT Insertion 20 2/5.71% (new)
Table 2. Patient ancestral’s countries of origin and genotype correlation.
ATP7B mutation Patient ancestral’s countries of origin
heterozygote c.2762G>A Germany, Poland
heterozygote c.3207C>A Native ancestor
heterozygote c.3207C>A Germany, Ireland, Italy, Native ancestor, Poland, Portugal
homozygote c.3207C>A Poland
homozygote c.3207C>A Switzerland
homozygote c.3207C>A Switzerland
homozygote c.3207C>A Switzerland
homozygote c.3207C>A Italy, Ukraine
heterozygote c.3402delC Brazil, Italy, Portugal
heterozygote c.3402delC Unknown
homozygote c.3402delC Brazil, Italy, Portugal
homozygote c.3818C>T Unknow
heterozygote c.4093insT Italy
[c.4093insT]/[c.2672G>T] Italy
[c.2336G>A]/[c.2018-2030del13] Italy
 heterozygote c.2304delC Poland
 heterozygote c.2305A>G Italy, Poland
 heterozygote c.2123T>C Unknow
[c.2304duplC]/[c.3207C>A] Germany, Italy, Poland
homozygote c.2336G>A Poland
heterozygote c.2304duplC Germany
heterozygote c.2304duplC Unknow
[Intron 1 c.51+4 A -->T]/[c.1934T>G] Italy, Portugal, Russia
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reported for the first time8. These two novel mutations might 
be pathogenic, as both result in a deviation in transcription 
and thereafter lead to a complete stop in the transcription 
with the consequent formation of a truncated protein.
The first mutation (c.2018-2030del13) was detected in a 
28 year-old female in whom the diagnosis of WD was sus-
pected since age 16, when she came down with hemolytic 
anemia and hepatitis. Abnormal copper metabolism was de-
tected by a combination of low serum levels of caeruloplas-
min and elevated urinary levels of copper. Excellent clinical 
outcomes were achieved with D-penicilamine treatment. 
Genetic analysis disclosed a deletion of 13 base pairs at exon 
7 (c.2018-2030del13) and a mutation leading to a stop in the 
transcription at exon 8 of gene ATP7B (c.2336G>A), thus con-
firming the diagnosis of WD on a molecular level. 
The second mutation (c.4093InsT) was detected in a 22 year-
old female, first admitted to the hospital with generalized ede-
ma, ascites and jaundice. Liver biopsy disclosed cirrhosis of un-
known origin. The diagnosis of WD was suggested after clinical 
observation of Kayser-Fleischer rings and low serum-levels of 
caeruloplasmin.  A relevant issue was that the patient is a first-
degree cousin of her husband. The results of direct sequencing 
revealed that the patient had an insertion mutation, which af-
fects the genetic transcription at exon 20 (c.4093insT) and, in 
another allele, a substitution mutation of nucleotide at exon 11 
(c.2672G>T), which, therefore, turns her into a compound het-
erozygote. The same analysis was performed in a DNA sample 
of her husband, which demonstrated that he is in turn hetero-
zygote for the same mutation at exon 20 (c.4093insT), but not at 
the second allele, consequently an asymptomatic carrier of WD.
Genotype-phenotype correlation
The genotype-phenotype correlation analysis is described in 
Table 3. Subjects homozygous for the most common mutation 
(n=5) had a mean age of disease onset of 33.4±4.82 years (me-
dian=33 years), compared to 15.7±3.21 years (median=17 years) 
for heterozygotes (n=3) and 19.5±8.55 years (median=18 years) 
for the remaining individuals (n=15). All five homozygous sub-
jects for the c.3207C>A had hepatic diseases, with three of them 
presenting both hepatic and neuropsychiatric symptoms.
DISCUSSION
This study analyzes the mutations of the ATP7B gene in 
a WD population from southern Brazil. Fourteen different 
mutations were found, reflecting the genetic heterogeneity 
of WD. The most common mutation in our sample was the 
c.3207C>A substitution at exon 14, followed by the c.3402delC 
at exon 15. These two different mutations account for about 
48.5% of the alleles studied, about half of the mutations iden-
tified in this population. We also describe two novel poten-
tially pathogenic mutations: c.2018-2030del13 at exon 7 and 
c.4093InsT at exon 20.
The c.3207C>A substitution at exon 14 represents 35 
to 50% of the WD alleles affected in the European popula-
tion6. Its frequency is highest in Poland and eastern Germany 
and decreases to the western and to the southern European 
countries9. The high rate of occurrence of this mutation in 
central and eastern Europe probably reflects the origin of this 
mutation in this very area11.
In Mediterranean countries there is a wide range of 
mutations, the frequency of each of them varies consid-
erably from country to country9. In continental Italy, the 
c.3207C>A is the most common mutation, with an allelic 
frequency of 13–17%12.
The study of Deguti et al.10, published in 2004, was the first 
to genotype Brazilian WD patients. The authors determined 
Genotype Index/non index (n)
Mean age at onset/
diagnosis (years)
Main affected organ
Organs involved
Liver (n) Brain (n)
[c.51+4A>T]/[c.1934T>G] 1.0 41, 44 0 1 B
[c.2336G>A]/[c.2336G>A] 1.0 15, 16 1 0 L
[c.2336G>A]/[c.2018-2030del13] 1.0 15, 15 1 0 L
[c.2123T>C]/[-] 1.0 18, 21 0 1 B
[c.2304delC]/[-] 1.0 12, 19 1 0 B, L
[c.2672G>T]/[-] 1.0 19, 20 1 0 L, K
[c.2304duplC]/[-] 2.0 14, 15 1 1 B, L, K
[c.2304duplC]/[c.3207C>A] 1.0 12, 13 0 1 B
[c.2762G>A]/[-] 1.0 26, 27 1 0 L
[c.3818C<T]/[-] 1.0 34, 36 0 1 B
[c.3402delC]/[-] 1.1 A, 12 2 0 B, L
[c.3402delC]/[c.3402delC] 1.0 16, 17 0 1 B
[c.4093InsT]/[c.2672G>T] 1.0 22, 22 1 0 L
[c.4093InsT]/[-] 0.1 A, 26 0 0 A
[c.3207C>A]/[-] 2.0 17, 18 1 1 B, L
[c.3207C>A]/[c.3207C>A] 3.2 33, 36 2 3 B, L, K
Table 3. ATP7B genotype and clinical characteristics in 23 Wilson’s disease patients from southern Brazil.
A: asymptomatic; L: liver; B: brain; K: kidney.
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that the c.3402delC at exon 15 was the most common mu-
tation, with an allelic frequency of 30.8%. The second most 
frequent mutation was the c.2123T>C at exon 8, with an al-
lelic frequency of 14.1%. The c.3207C>A substitution at exon 
14 was absent in the studied population10. These results differ 
dramatically from the ones reported here.
Characteristically, our study population from southern 
Brazil is composed mainly of subjects with a European ances-
try. This is the reflection of the European colonization to this 
region during the XIX century, particularly from Germany, 
Poland and Italy13. It differs from the rest of the country, where 
a more mixed origin predominates, mostly due to a higher 
prevalence of Native Indigenous and African ancestors14.
Considering that Brazil is a continental country, the study 
of the frequency of WD mutations is difficult because of the 
inhomogeneity of the immigration. As determined for oth-
er countries such as India15, China16, and USA17, the regional 
distribution of the WD mutations is important to be studied 
since these countries have a highly mixed population with di-
verse patterns of immigration.
Investigation of potential correlations between genotype and 
phenotype was hampered in this study by the rarity of most mu-
tations and by the small number of subjects analyzed. However, 
we were able to demonstrate that patients homozygous for the 
c.3207C>A mutation were older at the time of symptoms onset 
and diagnosis. These findings confirm previous data on correla-
tion of the c.3207C>A mutation and the disease onset11,17.
On the other hand, we could not detect an association 
of the c.3207C>A mutation with predominantly neurological 
manifestations, as described by Caca et al.11. Other groups 
also failed to demonstrate this correlation17,18. The lack of 
consensus in the literature regarding this issue could be ex-
plained by the observations that clinical manifestations of 
WD are heterogeneous even in patients carrying the same 
mutation. It is, therefore, hypothesized that other addition-
al genetic and/or environmental factors could influence the 
phenotypes of WD, such as dietary cooper intake, metallo-
thionein inducibility, the individual capacity to handle cop-
per overload, the ApoE genotype, human prion gene poly-
morphism and mutations in COMMD16,17,19-22.
  In conclusion, the results of the present study improve the 
knowledge of the molecular diagnosis of WD patients from south-
ern Brazil. Almost half of the mutations of the ATP7B gene were 
located at exons 14 and 15. Consequently, the identification of 
these most prevalent mutations provide basis to design appropri-
ate regional screening strategies for the genetic diagnosis of WD.
